
IntegriChain and Blue Fin Group Combine Forces
2 Minute Read
Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.

2 Minute Read
Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.

3 Minute Read
We ask market access leaders what they would change if they had the ability to launch their therapy all over again.

3 Minute Read
We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.

3 Minute Read
As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?

2 Minute Read
Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.

4 Minute Read
This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.

2 Minute Read
Founder and CEO Kevin Leininger celebrates IntegriChain's outstanding customers and our team of professionals around the globe on our 15th anniversary.

4 Minute Read
We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.

3 Minute Read
Examining common questions about the 340B program and what ICyte solutions are available to identify and act on non-compliance.